Methotrexate vs Tildrakizumab

## Methotrexate vs Tildrakizumab: Overview

This comparison examines the pharmacological differences between **Methotrexate** and **Tildrakizumab**.

## Mechanism of Action

**Methotrexate**: Dihydrofolate reductase inhibitor.

## Pharmacokinetics

**Half-life**: Methotrexate — 3-10 hours; Tildrakizumab — N/A.

## Chemical Properties

**Molecular Formula**: Methotrexate — C20H22N8O5; Tildrakizumab — N/A.

**Molecular Weight**: Methotrexate — 454.4400 g/mol; Tildrakizumab — N/A.

**Type**: Methotrexate — Small molecule; Tildrakizumab — Antibody.